<DOC>
	<DOC>NCT02111018</DOC>
	<brief_summary>Prospective, randomized non-blinded, controlled study to assess the feasibility of the CytoSorb as an adjunct to the standard of care in patients with rhabdomyolysis requiring renal replacement therapy.</brief_summary>
	<brief_title>Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis</brief_title>
	<detailed_description />
	<mesh_term>Rhabdomyolysis</mesh_term>
	<criteria>Subject is age 1880 Subjects present with rhabdomyolysis Subject requires renal replacement therapy and has undergone adequate volume resuscitation Subject is willing to comply with specified follow up requirements Subject or their legal guardian either declines or cannot give informed consent Subject is pregnant Subject has been previously enrolled in this clinical study Comorbid condition that may limit survival to â‰¤14 days Comorbid condition that could confound study results Subjects who are receiving immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>